Dae-Sung Kim
Director/Miembro de la Junta en Great Orient Chemical Pte Ltd. .
Cargos activos de Dae-Sung Kim
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
ID Biochem, Inc.
ID Biochem, Inc. Chemicals: SpecialtyProcess Industries Part of Pharmicell Co., Ltd., ID Biochem, Inc. is a South Korean company based in Ulsan, South Korea. The company specializes in the production of pharmaceuticals, including vaccines, anti-cancer drugs, and stem cell therapies. In 2012, ID Biochem was acquired by Pharmicell Co., Ltd. for $19.28 million. | Comptroller/Controller/Auditor | - | - |
Great Orient Chemical Pte Ltd. | Director/Miembro de la Junta | - | - |
Historial de carrera de Dae-Sung Kim
Antiguos cargos conocidos de Dae-Sung Kim.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
ISU ABXIS CO., LTD. | Director/Miembro de la Junta | 12/11/2010 | - |
Director Ejecutivo | 30/06/2014 | 24/03/2017 | |
Corporate Officer/Principal | 11/08/2011 | 30/06/2014 | |
ISU PETASYS CO., LTD. | Director/Miembro de la Junta | - | - |
Corporate Officer/Principal | - | - | |
ISU CHEMICAL CO., LTD | Director/Miembro de la Junta | 06/09/2010 | - |
Director Financiero/CFO | 06/09/2010 | - |
Formación de Dae-Sung Kim.
Seoul National University | Undergraduate Degree |
Estadísticas
Internacional
Corea del Sur | 6 |
Singapur | 2 |
Operativa
Director/Board Member | 4 |
Corporate Officer/Principal | 2 |
Director of Finance/CFO | 1 |
Sectorial
Process Industries | 3 |
Health Technology | 2 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 3 |
---|---|
ISU CHEMICAL CO., LTD | Process Industries |
ISU ABXIS CO., LTD. | Health Technology |
ISU PETASYS CO., LTD. | Electronic Technology |
Empresas privadas | 2 |
---|---|
ID Biochem, Inc.
ID Biochem, Inc. Chemicals: SpecialtyProcess Industries Part of Pharmicell Co., Ltd., ID Biochem, Inc. is a South Korean company based in Ulsan, South Korea. The company specializes in the production of pharmaceuticals, including vaccines, anti-cancer drugs, and stem cell therapies. In 2012, ID Biochem was acquired by Pharmicell Co., Ltd. for $19.28 million. | Process Industries |
Great Orient Chemical Pte Ltd. |
- Bolsa de valores
- Insiders
- Dae-Sung Kim
- Experiencia